People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CeloNova BioSciences, Inc. | — | Biotechnology | Series B | $20.8M | $827.2M | 2011 |
Michael W. Grunze at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael W. Grunze on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Harry R. Jacobson | 1 | 7 |
| Thomas W. Lyles, Jr. | 1 | 4 |
| Dennert O. Ware | 1 | 2 |
| Delores P. Williams | 1 | 1 |
| Goetz W. Richter | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.